glp 1 agonist therapy glp-1_analogs [TUSOM Evolution of GLP‐1 Receptor Agonists

The post hoc analysis of patients only from the PIONEER 6 (evaluating oral semaglutide) and SUSTAIN 6 (evaluating sc semaglutide) studies found a 23.8% reduction in MACEs associated with semaglutide treatment (HR 0.76, 95% CI 0.620.92), especially in the prevention of nonfatal stroke (HR 0.65, 95% CI 0.430.97) [62]

Gastric emptying and release of incretin hormones after glucose ingestion in humans

Tissue distribution of GLP-1R The presence of GLP-1R was first demonstrated in rat insulinoma RINm5F [368], RIN5AH [369], and RIN1046-38 cells [82] using cAMP accumulation assays and radioligand binding

1% achieving 20% WL respectively (Table 1) [45]

2022 AHA/ACC/HFSA guideline for the management of heart failure: Executive summary: A report of the American college of cardiology/American heart association joint committee on clinical practice guidelines